Copy number variation of the gene NCF1 is associated with rheumatoid arthritis.

AIMS The aim of this study was to investigate genetic variants in the gene neutrophil cytosolic factor 1 (NCF1) for association with rheumatoid arthritis (RA). In rodent models, a single-nucleotide polymorphism (SNP) in Ncf1 has been shown to be a major locus regulating severity of arthritis. Ncf1 encodes one of five subunits of the NADPH oxidase complex. In humans the genomic structure of NCF1 is complex, excluding it from genome-wide association screens and complicating genetic analysis. In addition to copy number variation of NCF1, there are also two nonfunctional pseudogenes, nearly identical in sequence to NCF1. We have characterized copy number variation and SNPs in NCF1, and investigated these variants for association with RA. RESULTS We find that RA patients are less likely to have an increased copy number of NCF1, 7.6%, compared with 11.6% in controls; p=0.037. We also show that the T-allele of NCF1-339 (rs13447) is expressed in NCF1 and significantly reduces reactive oxygen species production. INNOVATION This is the first finding of genetic association of NCF1 with RA. The detailed characterization of genetic variants in NCF1 also helps elucidate the complexity of the NCF1 gene. CONCLUSION These data suggest that an increased copy number of NCF1 can be protective against developing RA and add support to previous findings of a role of NCF1 and the phagocyte NADPH oxidase complex in RA pathogenesis.

[1]  U. Hellman,et al.  Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats. , 2011, Antioxidants & redox signaling.

[2]  M. Dinauer,et al.  p47phox Phox Homology Domain Regulates Plasma Membrane but Not Phagosome Neutrophil NADPH Oxidase Activation* , 2010, The Journal of Biological Chemistry.

[3]  Qing Song,et al.  A copy number variation in human NCF1 and its pseudogenes , 2010, BMC Genetics.

[4]  Annette Lee,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[5]  K. Berger,et al.  NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity , 2008, Malaria Journal.

[6]  L. Alfredsson,et al.  A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity , 2007, Arthritis research & therapy.

[7]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[8]  P. Gregersen,et al.  Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. , 2007, American journal of human genetics.

[9]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[10]  D. Goldblatt,et al.  Cutaneous and other lupus‐like symptoms in carriers of X‐linked chronic granulomatous disease: incidence and autoimmune serology , 2007, Clinical and experimental immunology.

[11]  J. Palmblad,et al.  Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase , 2006, Human mutation.

[12]  R. Holmdahl,et al.  A New Arthritis Therapy with Oxidative Burst Inducers , 2006, PLoS medicine.

[13]  Charlotte N. Henrichsen,et al.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes. , 2006, American journal of human genetics.

[14]  B. V. Pedersen,et al.  Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides , 2006, Arthritis research & therapy.

[15]  M. Bayés,et al.  Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. , 2006, American journal of human genetics.

[16]  G. V. Ommen,et al.  Copy number variation in regions flanked (or unflanked) by duplicons among patients with developmental delay and/or congenital malformations; detection of reciprocal and partial Williams-Beuren duplications , 2006, European Journal of Human Genetics.

[17]  L. Pérez-Jurado,et al.  Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23. , 2005, Genome research.

[18]  M. Alarcón‐Riquelme,et al.  Genetic aspects of rheumatic diseases , 2005, Scandinavian journal of rheumatology.

[19]  A. Forbes,et al.  NCF1 (p47phox) and NCF1 Pseudogenes Are Not Associated with Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[20]  P. Heyworth,et al.  Chronic granulomatous disease. , 2003, Current opinion in immunology.

[21]  R. Holmdahl.  Dissection of the genetic complexity of arthritis using animal models. , 2003, Journal of autoimmunity.

[22]  Diana Murray,et al.  Membrane Binding Mechanisms of the PX Domains of NADPH Oxidase p40 phox and p47 phox * , 2003, The Journal of Biological Chemistry.

[23]  S. Bloom,et al.  Association between p47phox pseudogenes and inflammatory bowel disease. , 2003, Blood.

[24]  A. Ekici,et al.  A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions leading to HMSN/HNPP , 2003, European Journal of Human Genetics.

[25]  Jerónimo Bravo,et al.  Binding of the PX domain of p47phox to phosphatidylinositol 3,4‐bisphosphate and phosphatidic acid is masked by an intramolecular interaction , 2002, The EMBO journal.

[26]  D. Noack,et al.  Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection. , 2002, Blood.

[27]  K. Rittinger,et al.  Architecture of the p40-p47-p67 phox Complex in the Resting State of the NADPH Oxidase , 2002, The Journal of Biological Chemistry.

[28]  M. de Boer,et al.  Gene-scan method for the recognition of carriers and patients with p47(phox)-deficient autosomal recessive chronic granulomatous disease. , 2001, Experimental hematology.

[29]  D. Goldblatt,et al.  Colitis in chronic granulomatous disease , 2001, Archives of disease in childhood.

[30]  S. Chanock,et al.  Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. , 2000, Blood.

[31]  A. Karlsson,et al.  Respiratory burst in human neutrophils. , 1999, Journal of immunological methods.

[32]  M. Tassabehji,et al.  A complete physical contig and partial transcript map of the Williams syndrome critical region. , 1999, Genomics.

[33]  P. Gregersen,et al.  The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[34]  E. Green,et al.  A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. , 1997, The Journal of clinical investigation.

[35]  J. Palmblad,et al.  Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden , 1995, Acta paediatrica.

[36]  H. Yap,et al.  Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. , 1994, Arthritis and rheumatism.

[37]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[38]  Jens Holmberg,et al.  Positional identification of Ncf1 as a gene that regulates arthritis severity in rats , 2003, Nature Genetics.

[39]  A S Rigby,et al.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. , 2000, Arthritis and rheumatism.